REQUEST A DEMO
Total
USD $0.00
Search more companies

Perintis Medik Sdn Bhd (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Perintis Medik Sdn Bhd Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Perintis Medik Sdn Bhd is an enterprise located in Malaysia, with the main office in Subang Jaya. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on July 31, 2006. The company’s latest financial report indicates a net sales revenue increase of 32.22% in 2022. Its total assets grew by 14.2% over the same period. The net profit margin of Perintis Medik Sdn Bhd increased by 2% in 2022.

Headquarters
65 Jalan Usj 21/11, Uep Subang Jaya
Subang Jaya; Selangor; Postal Code: 47630

Contact Details: Purchase the Perintis Medik Sdn Bhd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Perintis Medik Sdn Bhd report to view the information.
Registered Capital:
Purchase the Perintis Medik Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Perintis Medik Sdn Bhd report to view the information.
Incorporation Date:
July 31, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Perintis Medik Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
32.22%
Total operating revenue
32.22%
Operating profit (EBIT)
59.39%
EBITDA
52.17%
Net Profit (Loss) for the Period
56.72%
Total assets
14.2%
Total equity
19.17%
Operating Profit Margin (ROS)
2.88%
Net Profit Margin
2%
Return on Equity (ROE)
5.91%
Quick Ratio
0.32%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?